ECM
IDXX icon

Exchange Capital Management’s Idexx Laboratories IDXX Stock Holding History

Exchange Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18
Closed -$1K – 194
2014
Q4 		$1K Buy
+18
New +$1.26K ﹤0.01% 334

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Exchange Capital Management's IDXX Position: Q1 2015 in Review

Exchange Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2015, closing a stake of 18 shares — an estimated $1K sold.

Exchange Capital Management first reported a position in IDXX in Q4 2014 and held it in 1 quarter. The position peaked at $1K in Q4 2014. 344 funds tracked by Wall St. Rank hold IDXX as of Q1 2015.

  • Exchange Capital Management reported no remaining Idexx Laboratories position as of Q1 2015 after selling out during the quarter.
  • Exchange Capital Management sold 18 Idexx Laboratories shares in Q1 2015, an estimated $1K.
  • Exchange Capital Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 1 quarter.
  • Exchange Capital Management's Idexx Laboratories position peaked at $1K in Q4 2014.
  • 344 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2015.

Based on Exchange Capital Management's 13F filing for Q1 2015, filed 17 Apr 2015.